Loading clinical trials...
Loading clinical trials...
Mechanism Research of Traditional Chinese Medicine (the Comprehensive Treatment Regimen) in Treating Idiopathic Membranous Nephropathy by Genomewide Association Studies
The purpose of this study is to analysis the different genotype in the idiopathic membranous nephropathy patients which with different therapeutic outcomes after treated by the Comprehensive Treatment Regimen or immunosuppressive agents, and so as to looking for ideal markers to assess appropriate treatment approach and the long-term efficacy.
The primary objective of this study is to looking for the gene level predictors in the patients who suffered from idiopathic membranous nephropathy. And according to the predictors, the clinicians could make a decision which method should be taken on IMN patients, Traditional Chinese Medicine or western medicine, and could get better results.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
Yes
Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
Start Date
December 1, 2010
Primary Completion Date
August 1, 2013
Completion Date
August 1, 2013
Last Updated
April 23, 2013
80
ESTIMATED participants
The Comprehensive Treatment Regimen of Traditional Chinese Medicine
DRUG
The immunosuppressive agents
DRUG
Lead Sponsor
Shanghai University of Traditional Chinese Medicine
NCT03804359
NCT05782933
NCT03864250
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions